Advanced Medical Solutions Group PLC
LSE:AMS

Watchlist Manager
Advanced Medical Solutions Group PLC Logo
Advanced Medical Solutions Group PLC
LSE:AMS
Watchlist
Price: 211 GBX -1.17% Market Closed
Market Cap: 463.1m GBX
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+50%
5Y
+72%
10Y
+276%
Liabilities
+
3Y
+224%
5Y
+333%
10Y
+1 220%
Equity
+
3Y
+16%
5Y
+29%
10Y
+170%

Balance Sheet Decomposition
Advanced Medical Solutions Group PLC

397.4m
Assets
141.2m
Liabilities
397.4m
Assets
141.2m
Liabilities
Current Assets 134.3m
Cash & Short-Term Investments 19.3m
Receivables 50.9m
Other Current Assets 64.1m
Non-Current Assets 263.1m
PP&E 46.6m
Intangibles 213.3m
Other Non-Current Assets 3.3m
Current Liabilities 46.7m
Accounts Payable 32.8m
Short-Term Debt 9.5m
Other Current Liabilities 4.5m
Non-Current Liabilities 94.5m
Long-Term Debt 69.7m
Other Non-Current Liabilities 24.8m

Balance Sheet
Advanced Medical Solutions Group PLC

Rotate your device to view
Balance Sheet
Currency: GBP
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
6
6
4
3
3
5
1
2
2
4
7
9
5
17
34
51
62
76
65
54
73
82
60
0
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
73
82
60
0
Cash Equivalents
6
6
4
3
3
5
1
2
2
4
7
9
5
17
34
51
62
76
65
0
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
7
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
2
2
3
3
4
4
3
4
6
6
11
10
11
11
9
11
19
26
27
19
21
20
23
54
Accounts Receivables
2
2
2
3
3
4
3
4
6
5
10
9
10
11
9
10
19
25
26
18
18
18
21
0
Other Receivables
0
1
1
0
0
0
0
0
1
0
1
0
1
0
0
1
0
2
1
2
3
3
2
0
Inventory
1
1
1
2
2
2
2
2
3
3
7
7
8
8
9
11
11
15
18
21
19
28
36
55
Other Current Assets
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
2
2
2
3
2
1
3
0
Total Current Assets
9
9
8
8
9
11
13
15
13
13
25
26
26
38
54
75
95
119
112
97
115
132
122
126
PP&E Net
5
5
4
4
3
3
3
3
10
13
17
18
17
16
16
16
17
28
28
30
27
29
30
46
PP&E Gross
5
5
4
4
3
3
3
3
10
13
17
18
17
16
16
16
17
28
28
30
27
29
30
0
Accumulated Depreciation
5
5
6
7
8
9
8
9
9
8
7
8
10
10
12
14
16
20
23
26
28
31
35
0
Intangible Assets
0
2
2
2
2
2
2
2
2
2
14
13
14
13
12
14
15
15
33
42
41
48
56
99
Goodwill
0
0
0
0
0
0
0
0
3
3
39
38
39
37
35
40
42
42
54
69
66
71
80
115
Note Receivable
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
Long-Term Investments
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
1
2
2
3
4
3
2
1
0
0
0
1
0
0
0
1
1
0
Other Assets
0
0
0
0
0
0
0
0
3
3
39
38
39
37
35
40
42
42
54
69
66
71
80
115
Total Assets
14
N/A
16
+17%
15
-12%
14
-5%
14
+4%
16
+8%
19
+23%
25
+28%
30
+21%
33
+11%
100
+202%
98
-2%
97
-1%
105
+8%
117
+12%
145
+24%
169
+16%
205
+22%
227
+11%
239
+5%
250
+5%
281
+13%
289
+3%
389
+35%
Liabilities
Accounts Payable
1
1
2
1
1
2
2
2
3
2
4
3
2
2
3
3
3
4
7
7
5
6
6
0
Accrued Liabilities
1
1
0
0
1
1
1
1
3
2
2
2
3
3
4
5
6
6
3
4
6
7
4
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
2
3
0
0
0
0
0
1
1
1
1
1
1
3
Other Current Liabilities
0
0
0
0
0
0
1
1
1
1
4
1
3
3
3
6
4
8
5
2
5
8
10
2
Total Current Liabilities
2
2
2
2
2
3
3
4
6
4
11
9
8
8
10
15
13
19
17
15
17
23
22
44
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
19
12
0
0
0
0
0
9
9
10
9
9
8
78
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
3
3
3
3
2
3
3
3
6
9
7
10
11
21
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Other Liabilities
0
1
0
0
0
0
0
0
0
1
1
1
1
0
0
1
0
1
3
3
4
4
4
4
Total Liabilities
2
N/A
2
+15%
3
+9%
2
-8%
3
+9%
3
+20%
4
+17%
5
+34%
7
+47%
5
-25%
33
+540%
24
-28%
11
-54%
11
+3%
13
+12%
19
+51%
16
-16%
32
+100%
36
+10%
36
+2%
37
+1%
44
+21%
45
+1%
148
+229%
Equity
Common Stock
9
12
12
12
12
12
7
7
7
8
10
10
10
10
10
11
11
11
11
11
11
11
11
11
Retained Earnings
34
36
38
38
38
37
9
12
15
20
25
33
44
55
69
84
104
126
144
151
167
185
199
204
Additional Paid In Capital
37
38
38
38
38
38
0
0
0
0
32
32
32
33
33
34
35
35
36
36
37
37
37
38
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
7
Other Equity
0
0
0
0
0
0
0
0
0
0
0
1
0
5
9
3
3
1
0
4
2
3
4
5
Total Equity
12
N/A
14
+18%
12
-15%
12
-3%
12
+2%
13
+8%
16
+24%
20
+27%
23
+15%
28
+21%
66
+138%
74
+11%
86
+17%
93
+8%
104
+11%
126
+21%
152
+21%
173
+13%
191
+11%
202
+6%
213
+5%
237
+11%
244
+3%
241
-1%
Total Liabilities & Equity
14
N/A
16
+17%
15
-12%
14
-5%
14
+4%
16
+8%
19
+23%
25
+28%
30
+21%
33
+11%
100
+202%
98
-2%
97
-1%
105
+8%
117
+12%
145
+24%
169
+16%
205
+22%
227
+11%
239
+5%
250
+5%
281
+13%
289
+3%
389
+35%
Shares Outstanding
Common Shares Outstanding
94
142
142
142
142
142
143
143
145
155
204
205
207
208
209
210
213
214
215
215
216
217
217
218

See Also

Summary
AMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMS stock valuation using valuation multiples.
Wall Street Estimates
AMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 301,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.